IL151188A0 - Medicament for viral diseases - Google Patents

Medicament for viral diseases

Info

Publication number
IL151188A0
IL151188A0 IL15118801A IL15118801A IL151188A0 IL 151188 A0 IL151188 A0 IL 151188A0 IL 15118801 A IL15118801 A IL 15118801A IL 15118801 A IL15118801 A IL 15118801A IL 151188 A0 IL151188 A0 IL 151188A0
Authority
IL
Israel
Prior art keywords
medicament
viral diseases
viral
diseases
Prior art date
Application number
IL15118801A
Other languages
English (en)
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE2000109408 external-priority patent/DE10009408A1/de
Priority claimed from DE2000132874 external-priority patent/DE10032874A1/de
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of IL151188A0 publication Critical patent/IL151188A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D261/18—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/08—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D261/14—Nitrogen atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL15118801A 2000-02-28 2001-02-19 Medicament for viral diseases IL151188A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE2000109408 DE10009408A1 (de) 2000-02-28 2000-02-28 Arzneimittel gegen virale Erkrankungen
DE2000132874 DE10032874A1 (de) 2000-07-06 2000-07-06 Arzneimittelkombinationen gegen virale Erkrankungen
PCT/EP2001/001825 WO2001064755A2 (de) 2000-02-28 2001-02-19 Isoxazole gegen virale erkrankungen

Publications (1)

Publication Number Publication Date
IL151188A0 true IL151188A0 (en) 2003-04-10

Family

ID=26004561

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15118801A IL151188A0 (en) 2000-02-28 2001-02-19 Medicament for viral diseases

Country Status (13)

Country Link
US (1) US20030187028A1 (ko)
EP (1) EP1286974A2 (ko)
JP (1) JP2003526639A (ko)
KR (1) KR20020079963A (ko)
CN (1) CN1406233A (ko)
AU (1) AU3739801A (ko)
BR (1) BR0108723A (ko)
CA (1) CA2401405A1 (ko)
IL (1) IL151188A0 (ko)
MX (1) MXPA02008418A (ko)
PL (1) PL365124A1 (ko)
TR (1) TR200201954T2 (ko)
WO (1) WO2001064755A2 (ko)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030236287A1 (en) * 2002-05-03 2003-12-25 Piotrowski David W. Positive allosteric modulators of the nicotinic acetylcholine receptor
WO2007068380A1 (en) * 2005-12-15 2007-06-21 Bayer Healthcare Ag Diaryl urea for treating virus infections
US20130267517A1 (en) 2012-03-31 2013-10-10 Hoffmann-La Roche Inc. Novel 4-methyl-dihydropyrimidines for the treatment and prophylaxis of hepatitis b virus infection
KR20140143160A (ko) * 2012-03-31 2014-12-15 에프. 호프만-라 로슈 아게 B형 간염 바이러스 감염의 치료 및 예방을 위한 신규한 4-메틸-다이하이드로피리미딘
WO2014124092A2 (en) * 2013-02-07 2014-08-14 Tobira Therapeutics, Inc. Lamivudine salts
CN109970675A (zh) * 2018-05-28 2019-07-05 中国医学科学院医药生物技术研究所 一组硫脲化合物及其制备方法和应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2126329A (en) * 1936-03-20 1938-08-09 Hoffmann La Roche Amide derivatives of isoxazole carboxylic acids
PT727419E (pt) * 1992-12-29 2002-08-30 Abbott Lab Compostos intermediarios para a preparacao de inibidores da protease retroviral
DE69937904T2 (de) * 1998-03-11 2009-01-02 James W. Oak Park Williams Antivirale verwendungen von leflunomid produkten

Also Published As

Publication number Publication date
PL365124A1 (en) 2004-12-27
BR0108723A (pt) 2002-12-03
JP2003526639A (ja) 2003-09-09
TR200201954T2 (tr) 2002-12-23
KR20020079963A (ko) 2002-10-21
US20030187028A1 (en) 2003-10-02
CA2401405A1 (en) 2001-09-07
EP1286974A2 (de) 2003-03-05
CN1406233A (zh) 2003-03-26
AU3739801A (en) 2001-09-12
MXPA02008418A (es) 2003-02-12
WO2001064755A2 (de) 2001-09-07
WO2001064755A3 (de) 2002-06-20

Similar Documents

Publication Publication Date Title
AU2001244188A1 (en) Medicaments against viral diseases
EP1296699A4 (en) THERAPEUTIC AGENTS - III
PL359416A1 (en) Medicine comprising dicyanopyridine derivative
GB0023983D0 (en) Therapeutic compounds
GB0008710D0 (en) Therapeutic compounds
GB0016681D0 (en) Therapeutic compounds
IL154875A0 (en) Pyrazole derivatives for the treatment of viral diseases
GB0009605D0 (en) Medicaments
SG85231A1 (en) Disposable mask
GB0002312D0 (en) Medicaments
GB0028583D0 (en) Therapeutic compounds
GB0009612D0 (en) Therapeutic formulations
IL151188A0 (en) Medicament for viral diseases
EP1325751A4 (en) NEW MEDICAMENTS FOR THE TREATMENT OF LIVER DISEASES
HUP0000997A3 (en) New medicament combination
GB0015324D0 (en) Medicaments
EP1252895A4 (en) REMEDIES FOR OPHTHALMIC DISORDERS
EP1304117A4 (en) MEDIUM FOR BONE DISEASES
GB0013105D0 (en) Therapeutic compounds
GB0017092D0 (en) Medicament
GB0017076D0 (en) Medicament
GB0022521D0 (en) Medicinal compounds
GB0007628D0 (en) Medicinal compounds
GB0101470D0 (en) Medicament
GB0108590D0 (en) Medicament